This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Lymphoblastic Leukemia (ALL)
and you are
between 1 and 17
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The overall objective of this study is to continue to improve the cure rate of childhood acute lymphoblastic leukemia (ALL) in Singapore and Malaysia in the context of a multi-centre cooperative trial using a risk-stratified therapy based primarily on early response to therapy utilizing a simplified minimal residual disease (MRD-lite) platform.

Provided treatments

  • Drug: Prednisolone
  • Drug: Dexamethasone
  • Drug: L-Asparaginase
  • Drug: Vincristine
  • Drug: Methotrexate
  • Drug: Daunorubicin
  • Drug: Doxorubicin
  • Drug: Cyclophosphamide
  • Drug: Cytarabine
  • Drug: 6-Mercaptopurine
  • Drug: Thioguanine
  • Drug: Fludarabine
  • Drug: Imatinib

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02894645. The sponsor of the trial is National University Hospital, Singapore and it is looking for 500 volunteers for the current phase.
Official trial title:
Ma-Spore ALL 2010 Study